日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Citrobacter koseri tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial CSB-YP422125CWS
CSB-EP422125CWS
CSB-BP422125CWS
CSB-MP422125CWS
CSB-EP422125CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri ATP-dependent RNA helicase rhlB (rhlB) CSB-YP422126CWS
CSB-EP422126CWS
CSB-BP422126CWS
CSB-MP422126CWS
CSB-EP422126CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri Tat-linked quality control protein TatD (tatD) CSB-YP422127CWS
CSB-EP422127CWS
CSB-BP422127CWS
CSB-MP422127CWS
CSB-EP422127CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri tRNA1 (Val) (adenine (37)-N6)-methyltransferase CSB-YP422128CWS
CSB-EP422128CWS
CSB-BP422128CWS
CSB-MP422128CWS
CSB-EP422128CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri tRNA (cytidine/uridine-2'-O-)-methyltransferase TrmJ CSB-YP422129CWS
CSB-EP422129CWS
CSB-BP422129CWS
CSB-MP422129CWS
CSB-EP422129CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri Cytoskeleton protein rodZ (rodZ), partial CSB-YP422130CWS
CSB-EP422130CWS
CSB-BP422130CWS
CSB-MP422130CWS
CSB-EP422130CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri tRNA (Met) cytidine acetyltransferase TmcA, partial CSB-YP422131CWS
CSB-EP422131CWS
CSB-BP422131CWS
CSB-MP422131CWS
CSB-EP422131CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri Cell division protein ZipA homolog (zipA), partial CSB-YP422132CWS
CSB-EP422132CWS
CSB-BP422132CWS
CSB-MP422132CWS
CSB-EP422132CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri UPF0115 protein CKO_00454 (CKO_00454) CSB-YP422133CWS
CSB-EP422133CWS
CSB-BP422133CWS
CSB-MP422133CWS
CSB-EP422133CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri UPF0207 protein CKO_00504 (CKO_00504) CSB-YP422134CWS
CSB-EP422134CWS
CSB-BP422134CWS
CSB-MP422134CWS
CSB-EP422134CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri NADH-quinone oxidoreductase subunit K (nuoK), partial CSB-YP422135CWS1
CSB-EP422135CWS1
CSB-BP422135CWS1
CSB-MP422135CWS1
CSB-EP422135CWS1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri Periplasmic nitrate reductase (napA), partial CSB-YP422136CWS
CSB-EP422136CWS
CSB-BP422136CWS
CSB-MP422136CWS
CSB-EP422136CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri Multidrug resistance protein MdtB (mdtB), partial CSB-YP422137CWS
CSB-EP422137CWS
CSB-BP422137CWS
CSB-MP422137CWS
CSB-EP422137CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri Probable propionate kinase (pduW) CSB-YP422138CWS
CSB-EP422138CWS
CSB-BP422138CWS
CSB-MP422138CWS
CSB-EP422138CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri Cobalamin synthase (cobS), partial CSB-YP422139CWS1
CSB-EP422139CWS1
CSB-BP422139CWS1
CSB-MP422139CWS1
CSB-EP422139CWS1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP422140CWS
CSB-EP422140CWS
CSB-BP422140CWS
CSB-MP422140CWS
CSB-EP422140CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri Protein mgrB homolog (mgrB), partial CSB-YP422141CWS
CSB-EP422141CWS
CSB-BP422141CWS
CSB-MP422141CWS
CSB-EP422141CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri Peptidyl-tRNA hydrolase (pth) CSB-YP422142CWS
CSB-EP422142CWS
CSB-BP422142CWS
CSB-MP422142CWS
CSB-EP422142CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri UPF0263 protein CKO_01325 (CKO_01325) CSB-YP422143CWS
CSB-EP422143CWS
CSB-BP422143CWS
CSB-MP422143CWS
CSB-EP422143CWS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Citrobacter koseri UPF0056 inner membrane protein marC (marC), partial CSB-YP422144CWS1
CSB-EP422144CWS1
CSB-BP422144CWS1
CSB-MP422144CWS1
CSB-EP422144CWS1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×